MetaCap

Processa Pharmaceuticals (PCSA) vs Silo Pharma (SILO)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Processa Pharmaceuticals is the larger company by market cap ($4.4 million vs $3.7 million), about 1.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

PCSA+9.86%SILO+18.75%
+40%+8%-24%
Oct 7, 20261 yearNov 20, 2026
PCSA+2.63%SILO+16.33%
+29%+4%-22%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

PCSA versus SILO key metrics
MetricPCSASILO
Share price$1.56$1.71
Market cap$4.37M$3.69M
1-day change-7.69%-9.04%
EPS (TTM)$-68.29$-2.26
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$72.10K
Revenue growth (YoY)—0.00%
Net income (latest FY)$-13.56M$-4.23M
Gross margin—38.57%
Operating margin—-5936.95%
Net margin—-5863.50%
52-week high$8.88$10.43
52-week low$1.04$1.10
Distance from 52-week high-82.43%-83.60%
Average volume79.50K65.47K
Shares outstanding2.80M2.16M
Employees123
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Processa Pharmaceuticals

PCSA stock →

Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer therapy drugs to improve the safety and efficacy of cancer treatment in the United States. The company's drugs are modifications of existing FDA-approved oncology drugs, resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms for killing cancer cells.

Health Care · Biotechnology: Pharmaceutical Preparations · 12 employees

About Silo Pharma

SILO stock →

Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company.

Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees

PCSA vs SILO FAQ

Which is bigger, Processa Pharmaceuticals or Silo Pharma?

Processa Pharmaceuticals (PCSA) is larger, with a market capitalization of $4.37M compared with $3.69M for Silo Pharma (SILO).

Are Processa Pharmaceuticals and Silo Pharma in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons